
Miromatrix Medical Investor Relations Material
Latest events

Q2 2023
Miromatrix Medical
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Miromatrix Medical Inc
Access all reports
Miromatrix Medical Inc. is a biotechnology company focused on developing bioengineered organs and tissues for transplantation. The company uses its proprietary technology to create fully transplantable human organs, such as livers and kidneys, by repopulating decellularized animal organs with human cells. Miromatrix aims to address the global shortage of donor organs by providing alternative, lab-grown solutions for patients in need of transplants. The company's bioengineering platform is designed to produce organs that could potentially eliminate the need for immunosuppressive drugs post-transplant. The company is headquartered in Eden Prairie, Minnesota, and its shares are listed on the NASDAQ.
Latest articles
)
Moncler: From the Mountains to the Runway
The story of Moncler, all the way from its beginnings in the Alps to its journey to some of the most prestigious runways in the world.
16 Apr 2025
)
eToro: Innovation, Growth, and IPO Plans
eToro was founded in 2007 and has grown into a global trading platform with over 40 million users and an extensive offering across several asset classes.
10 Apr 2025
)
Yum! Brands: The Company Behind Pizza Hut, KFC, and Taco Bell
Yum! Brands started at PepsiCo in the 1970s and is home to some of the most well-known brands in the world, such as Pizza Hut, KFC, and Taco Bell.
9 Apr 2025
Ticker symbol
MIRO
Country
🇺🇸 United States